infectious-diseases

Documents about infectious-diseases

• Resilience of Belgian Cattle Farmers Towards Infectious Diseases Outbreaks.#162073NCBI PubMed Central
• Phase I Trial of Smallpox Vaccine#249687ClinicalTrials.gov
• Bacterial Pulmonary Infection in PICU#321530ClinicalTrials.gov
• Emergence and Spread of Artemisinin-Resistant Malaria in Zambia#353184bioRxiv / medRxiv
• How Re-Infections and Newborns Can Impact Visible and Hidden Epidemic Dynamics?#175862Apollo
• Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection#190637UNSWorks Repository
• Re-emergence of poliomyelitis in the Ukraine, caused by circulating vaccine-derived poliovirus type 2 (cVDPV2)#190651UNSWorks Repository
• Analysis of drug binding pockets and repurposing opportunities for twelve essential enzymes of ESKAPE pathogens#491831eScholarship
• Relevance of Systematic Pre-Biologic Infectious Screening in Chronic Inflammatory Rheumatic Diseases: A Retrospective Single-Center Study#288221HAL (France)
• Determination of intermediate state structures in the opening pathway of SARS-CoV-2 spike using cryo-electron microscopy.#383469Apollo
• Research intensity for neglected tropical diseases and other infectious diseases before and after the COVID-19 pandemic.#439226NCBI PubMed Central
• Semi-analytical hierarchical Bayesian inference of nonlinear model structure in stochastic dynamics: Applied to compartmental models of infectious diseases#358746PLOS
• Activation of the Listeria monocytogenes Virulence Program by a Reducing Environment#491807eScholarship
• Government health care worker training needs for schistosomiasis morbidity management#10136bioRxiv / medRxiv
• Antigenic Competition in HIV Preventive Vaccines#18704ClinicalTrials.gov
• Experimental Ebola Vaccine Trial#121433ClinicalTrials.gov
• mRNA vaccines for infectious diseases - advances, challenges and opportunities.#125583NCBI PubMed Central
• Study of a Flu Vaccine in Children#154727ClinicalTrials.gov
• Trial to Evaluate L9LS in Healthy Adults#245580ClinicalTrials.gov
• Study of Tecovirimat for Human Mpox Virus#245589ClinicalTrials.gov
• Anthrax AV7909 Liquid vs Lyophilized#290838ClinicalTrials.gov
• TY800 Dose Escalation (Typhoid)#290851ClinicalTrials.gov
• A genome-resolved view of the wastewater RNA virome#296524bioRxiv / medRxiv
• The Lancet Infectious Diseases Commission on Antimicrobial Resistance: 6 Years Later#323868Scholarly Commons at Boston University School of Law
• Adaptive COVID-19 Treatment Trial (ACTT)#356522ClinicalTrials.gov
• Combination Study With MVA BN and Dryvax#366645ClinicalTrials.gov
• Within-host pathogen population diversity predicts treatment response in tuberculosis#379856bioRxiv / medRxiv
• Large language models enable consensus-level interpretation in metagenomic diagnostics#610887bioRxiv / medRxiv
• 25 U.S.C. § 198 — Contagious and infectious diseases; quarantine#583433US Code (LII)
• Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR*ICU) Trial#125888ClinicalTrials.gov
• Activity of the Pore-Forming Virulence Factor Listeriolysin O Is Reversibly Inhibited by Naturally Occurring S-Glutathionylation#491833eScholarship
• Vaccination for Recovered Inpatients With COVID-19 (VATICO)#123546ClinicalTrials.gov
• UMD rPA Regimen Trial in Adults#127667ClinicalTrials.gov
• Climate change and infectious diseases: breaking the poverty-disease-environment trap.#174668NCBI PubMed Central
• Integration of Hypertension Management in HIV Care in Uganda#217127ClinicalTrials.gov
• Converting Passive Filtration Media into Active Air Biofiltration Surfaces for Airborne Viral Reduction#241512bioRxiv / medRxiv
• Sensitivity and specificity of tuberculosis screening tools in people with diabetes#243517bioRxiv / medRxiv
• Challenge Model for Assessment of Human TB Immunity#268088ClinicalTrials.gov
• Detecting simulated pathogen releases in a real-world health data set#272001bioRxiv / medRxiv
• Reducing Inappropriate Antibiotic Prescribing by Primary Care Clinicians#272370ClinicalTrials.gov
• Phase 2 Shigella Vaccine and Challenge#321563ClinicalTrials.gov
• Tuberculosis Prevention for HIV Infected Adults#325320ClinicalTrials.gov
• Local Influenza Forecasts Outperform State-Level Forecasts in the United States#343645bioRxiv / medRxiv
• Serological Markers Predict Plasmodium vivax Relapses in Returning Indonesian Soldier Cohorts#353185bioRxiv / medRxiv
• Characterisation of disease progression in hantavirus haemorrhagic fever with renal syndrome#373579bioRxiv / medRxiv
• Network on Antimicrobial Resistance in Staphylococcus Aureus#390946ClinicalTrials.gov
• Scleroderma: Cyclophosphamide or Transplantation#432783ClinicalTrials.gov
• Ambient-Temperature Extraction-Free One-Pot CRISPR Detection of Mycobacterium tuberculosis#471402bioRxiv / medRxiv
• An age-stratified mathematical model to inform optimal measles vaccination strategies#480188bioRxiv / medRxiv
• Smartphone barrier: uncovering the digital divide in mHealth prevention among disadvantaged middle-aged and older-aged UK communities#339607Apollo